Alissa Visram

809 citations
57 papers · 403 indexed · h-index 12
Topics
Multiple Myeloma Research and Treatments (46 papers)Protein Degradation and Inhibitors (24 papers)Peptidase Inhibition and Analysis (11 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE

In The Last Decade

Alissa Visram

50 papers receiving 395 citations

Peers

Alissa Visram
Comparison fields: 5 of 49
  • Hematology 244
  • Oncology 198
  • Molecular Biology 158
  • Immunology 76
  • Epidemiology 53
Replace Ender Soydan with:
Ender Soydan Türkiye
Paul Koller United States
Jae-Sook Ahn South Korea
Giovanni Marconi Italy
Donald Woytowitz United States
Leandro de Pádua Silva United States
Katja Matthes Germany
Yasmin Abaza United States
Chrissy Giles United Kingdom
Gregory J. Gerstner United States
Alissa Visram relative to Ender Soydan Türkiye Ender Soydan's profile →
Citations per field
00.5×10×15×19.6×
Ender Soydan · 1×
Citations per year

Countries citing papers authored by Alissa Visram

Since Specialization
Citations

This map shows the geographic impact of Alissa Visram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa Visram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa Visram more than expected).

Fields of papers citing papers by Alissa Visram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa Visram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa Visram. The network helps show where Alissa Visram may publish in the future.

Co-authorship network of co-authors of Alissa Visram

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa Visram. A scholar is included among the top collaborators of Alissa Visram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa Visram. Alissa Visram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 2
6 8
7 0
8 0
9 1
10 1
11 6
12 4
13 2
14 16
15 33
16 3
17 12
18 2
19 1
20 20

About Alissa Visram

Alissa Visram is a scholar working on Hematology, Oncology and Transplantation, having authored 57 papers that have together received 403 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (46 papers), Protein Degradation and Inhibitors (24 papers) and Peptidase Inhibition and Analysis (11 papers). The work is most often cited by research in Hematology (244 citations), Oncology (198 citations) and Hepatology (44 citations). Alissa Visram has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include Shaji Kumar, Taxiarchis Kourelis, Jordan J. Feld, Angela Dispenzieri, Robert A. Kyle, S. Vincent Rajkumar, Scott McComb, Seung‐Hwan Lee, Donald Bastin and Rahma Warsame. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026